Makuake, Inc. (TYO:4479)

Elevation Oncology Cash Flow Statement

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net Income	-	-132	-503	-1,264	326	512
Depreciation & Amortization	-	120	35	172	110	69
Loss (Gain) From Sale of Assets	-	-	-	1,009	-	-
Loss (Gain) From Sale of Investments	-	78	24	-47	-	-
Other Operating Activities	-	-10	49	-96	-213	-46
Change in Accounts Receivable	-	63	-144	212	-21	-335
Change in Accounts Payable	-	-14	5	-260	-282	783
Change in Other Net Operating Assets	-	-1,199	195	-553	231	1,581
Operating Cash Flow	-	-1,094	-339	-827	151	2,564
Operating Cash Flow Growth	-	-	-	-	-94.11%	560.83%
Capital Expenditures	-	-3	-7	-21	-7	-7
Sale (Purchase) of Intangibles	-	-383	-575	-488	-306	-213
Investment in Securities	-	-	-	32	-148	-10
Other Investing Activities	-	110	-	2	-125	-17
Investing Cash Flow	-	-276	-582	-475	-586	-247
Short-Term Debt Repaid	-	-	-	-	-	-50
Long-Term Debt Repaid	-	-	-	-	-	-27
Total Debt Repaid	-	-	-	-	-	-77
Net Debt Issued (Repaid)	-	-	-	-	-	-77
Issuance of Common Stock	-	18	14	33	3,915	1,990
Financing Cash Flow	-	18	14	33	3,915	1,913
Miscellaneous Cash Flow Adjustments	-	-	-	-	1	-
Net Cash Flow	-	-1,352	-907	-1,269	3,481	4,230
Free Cash Flow	-	-1,097	-346	-848	144	2,557
Free Cash Flow Growth	-	-	-	-	-94.37%	670.18%
Free Cash Flow Margin	-	-30.04%	-9.08%	-20.16%	3.12%	79.29%
Free Cash Flow Per Share	-	-86.40	-27.46	-67.69	11.46	213.98
Cash Income Tax Paid	-	10	-49	96	214	47
Levered Free Cash Flow	-	-1,450	-755.63	-1,231	-195.38	2,280
Unlevered Free Cash Flow	-	-1,450	-755.63	-1,231	-195.38	2,280

Source: S&P Global Market Intelligence. Standard template. Financial Sources.